Smoking Cessation Intervention for Thoracic Patients

Study summary

The primary aim of the proposed study is to develop and assess the feasibility of delivering a smoking cessation intervention to patients undergoing lung surgery that begins before surgery and continues up to 3 months post-discharge. The secondary aim is to assess smoking cessation rates 3 months following surgery.

Ask AI to explain this study

Start here

Key things to know

Main goalTreatment

This describes the study’s primary purpose.

What is being studiedSmoking cessation counseling and varenicline

The study team can explain what participation involves.

Who it may be forLung Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Oct 12, 2018 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Phase 1 / Phase 2

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Massachusetts General Hospital

Study sponsor

Study overview

What this study is about

Purpose: Treatment
Study type: Interventional
Phase: Phase 1 / Phase 2
Sponsor: Massachusetts General Hospital
Interventions being studied: Behavioral: Smoking cessation counseling; Drug: varenicline

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach

Surgery→Supportive or behavioral care→

Study topics

Before surgery (neoadjuvant)→

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

A patient is eligible if he/she: 1. Is scheduled for a lung resection surgery with either a lung cancer diagnosis or a potential lung cancer diagnosis 2. Smoked a cigarette in the past 2 weeks 3. Is willing to make a pre-surgical quit attempt

Reasons someone may not be able to joinExclusion criteria

Patients will be excluded from the intervention group if they are: 1. Non-English speaking 2. Determined medically ineligible by their surgeon 3. Suffering from psychosis or dementia 4. Have been taking Varenicline for longer than three weeks 5. Have been taking Bupropion (for smoking cessation purposes) for more than three weeks 6. Is otherwise unable to participate in the intervention.

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

Massachusetts General HospitalBoston, Massachusetts

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Oct 12, 2018. Always confirm current availability with the study team.

View original record ↗